H. Vuorinen-Markkola

发表

Lowering of triglycerides by gemfibrozil affects neither the glucoregulatory nor antilipolytic effect of insulin in Type 2 (non-insulin-dependent) diabetic patients

M. Taskinen, H. Yki-Järvinen, H. Vuorinen-Markkola, 1993, Diabetologia.

Postmarathon paradox: insulin resistance in the face of glycogen depletion.

L. Korányi, R. Bourey, A. Lamminen, 1996, The American journal of physiology.

Mechanisms of hepatic and peripheral insulin resistance during acute infections in humans.

H. Yki-Järvinen, V. Koivisto, H. Vuorinen-Markkola, 1992, The Journal of clinical endocrinology and metabolism.

Decreasing triglyceride by gemfibrozil therapy does not affect the glucoregulatory or antilipolytic effect of insulin in nondiabetic subjects with mild hypertriglyceridemia.

M. Taskinen, H. Yki-Järvinen, H. Vuorinen-Markkola, 1995, Metabolism: clinical and experimental.

LDL particle size in mildly hypertriglyceridemic subjects: no relation to insulin resistance or diabetes.

M. Taskinen, H. Vuorinen-Markkola, P. Knudsen, 1995, Atherosclerosis.

Gemfibrozil reduces postprandial lipemia in non-insulin-dependent diabetes mellitus.

M. Taskinen, M. Syvänne, H. Vuorinen-Markkola, 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

Antihypertensive therapy with enalapril improves glucose storage and insulin sensitivity in hypertensive patients with non-insulin-dependent diabetes mellitus.

H. Yki-Järvinen, H. Vuorinen-Markkola, Hannele Yki-Järvinen, 1995, Metabolism: clinical and experimental.

Exercise reduces muscle glucose transport protein (GLUT-4) mRNA in type 1 diabetic patients.

L. Korányi, R. Bourey, V. Koivisto, 1993, Journal of applied physiology.

Effects of Gemfibrozil on Low-Density Lipoprotein Particle Size, Density Distribution, and Composition in Patients With Type II Diabetes

M. Taskinen, H. Vuorinen-Markkola, T. Kuusi, 1993, Diabetes Care.

Effect of 3 Months of Antimicrobial Treatment With Clarithromycin in Acute Non–Q-Wave Coronary Syndrome

M. Nieminen, J. Sinisalo, V. Valtonen, 2002, Circulation.

Defect in insulin action on expression of the muscle/adipose tissue glucose transporter gene in skeletal muscle of type 1 diabetic patients.

M. Mueckler, H. Yki-Järvinen, R. Bourey, 1992, The Journal of clinical endocrinology and metabolism.

Level of skeletal muscle glucose transporter protein correlates with insulin-stimulated whole body glucose disposal in man

M. Permutt, M. Mueckler, H. Yki-Järvinen, 1991, Diabetologia.

Hyperuricemia and insulin resistance.

H. Yki-Järvinen, H. Vuorinen-Markkola, 1994, The Journal of clinical endocrinology and metabolism.

Effect of gemfibrozil on high density lipoprotein subspecies in non-insulin dependent diabetes mellitus. Relations to lipolytic enzymes and to the cholesteryl ester transfer protein activity.

M. Taskinen, H. Vuorinen-Markkola, J. Kahri, 1993, Atherosclerosis.

No Evidence for Short-Term Regulation of Plasminogen Activator Inhibitor Activity by Insulin in Man

H. Yki-Järvinen, H. Vuorinen-Markkola, I. Puhakainen, 1992, Thrombosis and Haemostasis.

Simultaneous assessment of insulin secretion and insulin sensitivity using a hyperglycemia clamp.

T. Jenssen, H. Vuorinen-Markkola, G. Bolli, 1992, The Journal of clinical endocrinology and metabolism.

Mechanisms of Hyperglycemia-Induced Insulin Resistance in Whole Body and Skeletal Muscle of Type I Diabetic Patients

H. Yki-Jărvinen, H. Vuorinen-Markkola, V. Koivisto, 1992, Diabetes.

Post‐marathon Paradox in IDDM: Unchanged Insulin Sensitivity in Spite of Glycogen Depletion

P. Ebeling, H. Vuorinen-Markkola, J. Tuominen, 1997, Diabetic medicine : a journal of the British Diabetic Association.

Guar gum in insulin-dependent diabetes: effects on glycemic control and serum lipoproteins.

V. Koivisto, H. Vuorinen-Markkola, V. Koivisto, 1992, The American journal of clinical nutrition.